Strive Health, a national leader in value-based kidney care, secured $550 million in combined Series D equity and debt financing. New Enterprise Associates (NEA) led the $300 million equity round, while Hercules Capital spearheaded the $250 million debt financing. This significant Strive Health funding will scale the company's innovative care model.
Scaling Value-Based Kidney Care
The funding enables Strive Health to expand its services to more patients and providers. It will strengthen strategic partnerships and grow multi-specialty offerings. Furthermore, the company plans to enhance its value-based care model using advanced technology, including AI-driven tools and analytics.
Strive Health manages nearly $5 billion in annual medical spend.
The company partners with over 6,500 providers across all 50 states, serving over 145,000 people. Its approach to chronic kidney disease emphasizes early intervention and preventative care. This model has demonstrated a 20% reduction in total kidney care costs and a 41% decrease in hospitalizations. Strive Health also reports 94% overall patient satisfaction.
Other investors in the equity round included CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures, Redpoint, and funds managed by affiliates of BlackRock, Inc. This Strive Health funding highlights the growing focus on value-based care models in healthcare. The company's expansion will further impact chronic disease management, similar to efforts by Oak Street Health or ChenMed.
